Azymus Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.04 Cr
- Paid Up Capital ₹ 1.04 Cr
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.50 M
- Satisfied Charges ₹ 1.40 Cr
- Revenue Growth 30000.00%
- Profit Growth -52.58%
- Ebitda -122.69%
- Net Worth -64.92%
- Total Assets -14.46%
About Azymus Lifesciences
Azymus Lifesciences Private Limited (ALPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 18 December 2018 (Six years and two months 8 days old ). Its registered office is in Chamrajnagar, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.04 Cr and a paid-up capital of Rs 1.04 Cr.
The company currently has active open charges totaling ₹9.50 M. The company has closed loans amounting to ₹1.40 Cr, as per Ministry of Corporate Affairs (MCA) records.
Puneeth Adishesha, Ravi Shivanna, Ashwini Savanth, and One other member serve as directors at the Company.
Company Details
- Location
Chamrajnagar, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U93000KA2018PTC119605
- Company No.
119605
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Dec 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
What products or services does Azymus Lifesciences Private Limited offer?
Azymus Lifesciences Private Limited offers a wide range of products and services, including Flavours & Aromatics, Food Additive, Bird Food, Poultry & Animal Food, Feed Additives, Textile, Dyeing & Finishing Chemical, Textile Chemical, Animal Feed Supplement, Industrial Chemicals & Supplies, Water Treatment Chemicals, Animal Feed Enzymes.
Who are the key members and board of directors at Azymus Lifesciences?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Puneeth Adishesha  | Director | 18-Dec-2018 | Current |
| Ravi Shivanna | Director | 18-Dec-2018 | Current |
| Ashwini Savanth | Additional Director | 03-Nov-2024 | Current |
| Umesh Nanjundaiah | Additional Director | 03-Nov-2024 | Current |
Financial Performance of Azymus Lifesciences.
Azymus Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 30000% increase. The company also saw a substantial fall in profitability, with a 52.58% decrease in profit. The company's net worth observed a substantial decline by a decrease of 64.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Azymus Lifesciences?
In 2021, Azymus Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.95 Cr
₹1.40 Cr
Charges Breakdown by Lending Institutions
- Others : 0.95 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 May 2020 | Others | ₹9.50 M | Open |
| 16 Dec 2019 | Karnataka State Financial Corporation | ₹1.40 Cr | Satisfied |
How Many Employees Work at Azymus Lifesciences?
Unlock and access historical data on people associated with Azymus Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Azymus Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Azymus Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
